Q&A With Marco Carbone From University of Cambridge: Developing A Scoring System To Predict Primary Biliary Cholangitis

Video

When treating liver disease every advantage can help doctors get their patients the care they need before the condition progresses further. A recent study looked at the potential of developing a scoring system to look at risks for this patient population.

When treating liver disease every advantage can help doctors get their patients the care they need before the condition progresses further. A recent study looked at the potential of developing a scoring system to look at risks for this patient population.

Marco Carbone, MD, from the University of Cambridge discussed why the system was being developed and what it could mean to patient care during the annual Liver Meeting in San Francisco.

Related Videos
Andrew Talal, MD | Credit: University at Buffalo
Andrew Talal, MD | Credit: University at Buffalo
Megan Rose Curtis, MD | Credit: Megan Rose Curtis on LinkedIn
Wei Zhang, MD, PhD | Credit: Mass General Brigham
Women at 50% Greater Risk Progressing from Alcoholic Hepatitis Cirrhosis than Men
Nancy Reau, MD: Larsucosterol for Alcohol-Associated Hepatitis
Taha Qazi, MD: Evolving Bariatric Surgery Value in GI
Taha Qazi, MD: Addressing Smoking Cessation in the GI Office
© 2024 MJH Life Sciences

All rights reserved.